Polycyanoacrylate porous material for bone tissue substitution

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Drug Delivery Systems

Background:

• Biodegradable polymers are crucial for medical implants.
• Controlling drug release rates is essential for effective therapies.
• Existing materials may pose risks of contamination or have limited release profiles.

Purpose of the Study:

• To design and demonstrate a porous, biodegradable material for bimodal drug elution.
• To develop a method for controlling the biodegradation rate of poly-2-cyanoacrylic polymers.
• To ensure the safety and efficacy of novel drug-eluting implants.

Main Methods:

• Synthesis of a porous biodegradable material incorporating nanocapsules.
• In vivo testing of a completely safe synthetic material, free from prion and virus contamination risks.
• Chemical modification of polyethyl-2-cyanoacrylate copolymers using novel perfluorinated 2-cyanoacrylic esters.
• Incorporation of internal imide-cycle formation to retard enzymatic hydrolysis.

Main Results:

• Successful proof-of-concept for a bimodal drug-eluting implant.
• Demonstration of a safe, synthetic material suitable for in vivo applications.
• Development of a method to control the biodegradation rate of the polymer.
• Retarded enzymatic hydrolysis achieved through chemical modification.

Conclusions:

• The developed porous biodegradable material offers a promising platform for advanced drug delivery.
• The novel chemical modifications allow for tunable biodegradation and controlled release kinetics.
• This technology presents a safe and effective approach for bimodal drug-eluting implants.